33P - Radiographic screening for lung cancer in Varese, Italy: cost-effectiveness analysis

Date 28 March 2014
Event ELCC 2014
Session Lunch and poster display session
Topics Bioethics, Legal, and Economic Issues
Cancer Aetiology, Epidemiology, Prevention
Lung and other Thoracic Tumours
Presenter Andrea Imperatori
Citation Journal of Thoracic Oncology (2014) 9 (Supplement 9): S7-S52. 10.1097/JTO.0000000000000131
Authors A. Imperatori1, P. Pertile2, A. Poli3, N. Rotolo1, M. Castiglioni1, D. Di Natale1, W. Mantovani3, M. Paolucci4, A. Paddeu5, L. Dominioni1
  • 1Center For Thoracic Surgery, University of Insubria, 21100 - Varese/IT
  • 2Department Of Economics, University of Verona, Verona/IT
  • 3Department Of Public Health, University of Verona, Verona/IT
  • 4Department Of Radiology, Ospedale S. Antonio Abate, Gallarate/IT
  • 5Respiratory Care Unit, Ospedale S. Anna, San Fermo della Battaglia, Como/IT


Screening for lung cancer (LC) has recently been shown to reduce LC mortality, however the cost-effectiveness of LC screening in the community is uncertain. In the PREDICA project (ISRCTN90639073), an observational population-based chest X-ray (CXR) screening that compared the screening invitees (PREDICA Cohort) to the local reference population receiving National Health Service (NHS) usual care (Control Group), we showed that screening reduced LC mortality by 18%. The present study analyzes in the PREDICA Cohort the cost-effectiveness of CXR screening for LC.